Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · IEX Real-Time Price · USD
30.22
-0.73 (-2.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Kymera Therapeutics Employees
Kymera Therapeutics had 187 employees as of December 31, 2023. The number of employees increased by 20 or 11.98% compared to the previous year.
Employees
187
Change (1Y)
20
Growth (1Y)
11.98%
Revenue / Employee
$424,668
Profits / Employee
-$826,690
Market Cap
1.85B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 187 | 20 | 11.98% |
Dec 31, 2022 | 167 | 26 | 18.44% |
Dec 31, 2021 | 141 | 66 | 88.00% |
Dec 31, 2020 | 75 | 20 | 36.36% |
Dec 31, 2019 | 55 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
AMN Healthcare Services | 18,223 |
Warby Parker | 3,491 |
Amphastar Pharmaceuticals | 1,761 |
Novavax | 1,543 |
NovoCure | 1,453 |
LeMaitre Vascular | 630 |
Beam Therapeutics | 507 |
KYMR News
- 18 days ago - Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting - GlobeNewsWire
- 4 weeks ago - Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting - GlobeNewsWire
- 4 weeks ago - Kymera Therapeutics to Participate in Upcoming June Investor Conferences - GlobeNewsWire
- 5 weeks ago - Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting - GlobeNewsWire
- 5 weeks ago - Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting - GlobeNewsWire
- 7 weeks ago - Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting - GlobeNewsWire
- 7 weeks ago - Kymera Therapeutics to Participate in Upcoming May Investor Conferences - GlobeNewsWire
- 2 months ago - Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire